Dose-response meta-analysis of 21 placebo-controlled trials in adults with insomnia disorder: daridorexant, lemborexant and suvorexant improved sleep continuity with dose, but effects mostly plateaued within approved dose ranges, suggesting limited benefit from higher doses.
Meta-analysisn = 21 trials
Caiazza et al. Dose-response meta-analysis of dual orexin receptor antagonists on sleep parameters and implications for orexin-mediated arousal